COMPOUND HETEROZYGOSITY HB-S HB HOPE (BETA(136)GLY-]ASP) - A PITFALL IN THE NEWBORN SCREENING FOR SICKLE-CELL DISEASE

Citation
R. Ducrocq et al., COMPOUND HETEROZYGOSITY HB-S HB HOPE (BETA(136)GLY-]ASP) - A PITFALL IN THE NEWBORN SCREENING FOR SICKLE-CELL DISEASE, Journal of medical screening, 5(1), 1998, pp. 27-30
Citations number
21
Categorie Soggetti
Public, Environmental & Occupation Heath
ISSN journal
09691413
Volume
5
Issue
1
Year of publication
1998
Pages
27 - 30
Database
ISI
SICI code
0969-1413(1998)5:1<27:CHHHH(>2.0.ZU;2-A
Abstract
The presence of Hb Hope associated with Hb S may represent a pitfall ( false positive) in the neonatal detection of sickle cell disease by tw o of the most widely used analytical methods in screening programmes-i soelectric focusing (IEF) and high performance liquid chromatography ( HPLC). This example illustrates the need to improve analytical strateg ies to avoid unnecessary anxiety and summoning of families often from a cultural background in which testing of the father is difficult to o btain. It is suggested that using two independent HPLC procedures migh t improve the specificity of the screening strategies. Additionally, s imple procedures for detection of the most common mutations of the bet a globin gene on DNA extracted from dried blood specimens could be eas ily developed for the control of abnormal samples. These procedures co uld be introduced into the analytical strategy.